Evidence map›Paper›PMID 41179656›Full record

ArticleFrontiers in oncology2025

Trans RCED-UNet3+: a hybrid CNN-transformer model for precise lung nodule segmentation.

Sadaf Raza, Razia Zia, Irfan Ahmed Usmani, Nouf Abdullah Almujally, Nada Alasbali, Muhammad Hanif

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sadaf RazaDepartment of Electronic Engineering, Sir Syed University of Engineering & Technology, Karachi, Pakistan.
Razia ZiaDepartment of Electronic Engineering, Sir Syed University of Engineering & Technology, Karachi, Pakistan.
Irfan Ahmed UsmaniDepartment of Biomedical Engineering, Salim Habib University (Formerly Barrett Hodgson University), Karachi, Pakistan.
Nouf Abdullah AlmujallyDepartment of Information Systems, College of Computer and Information Sciences, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Nada AlasbaliDepartment of Informatics and Computer Systems, College of Computer Science, King Khalid University, Abha, Saudi Arabia.
Muhammad HanifDepartment of Informatics, School of Business, Örebro Universitet, Örebro, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Precisely segmenting lung nodules in CT scans is essential for diagnosing lung cancer, though it is challenging due to the small size and intricate shapes of these nodules. Methods: This study presents Trans RCED-UNet3+, an enhanced version of the RCED-UNet3+ framework designed to address these challenges. The model features a transformer-based bottleneck that captures global context and long-range dependencies, along with residual connections that facilitate efficient feature flow and prevent gradient loss. To improve boundary accuracy, we employ a hybrid loss function that combines Dice loss with Binary Cross-Entropy, enhancing the clarity of nodule edges. Results: Evaluation on the LIDC-IDRI dataset demonstrates a notable advancement, as Trans RCED-UNet3+ achieves a Dice score of 0.990, exceeding the original model's score of 0.984. Discussion: These findings underscore the value of merging convolutional and transformer architectures, delivering a robust approach for precise segmentation in medical imaging. This model enhances the detection of subtle and irregular structures, enabling more accurate lung cancer diagnoses in clinical environments.

Indexed as

hybrid loss functionLIDC-IDRIlung noduleRCED-UNet 3+transformer bottleneck

Identifiers

PMID41179656
PMCPMC12571626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.